Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 9

Results For "Strides"

135 News Found

Piramal Pharma launches new campaign for 'Polycrol' with Brand Ambassador Jisshu Sengupta
News | May 09, 2024

Piramal Pharma launches new campaign for 'Polycrol' with Brand Ambassador Jisshu Sengupta

the campaign emphasizes the brand's reliability and effectiveness in providing timely relief


Bayer secures full ownership in Bayer Zydus Pharma by acquiring remaining 25% stake
News | May 03, 2024

Bayer secures full ownership in Bayer Zydus Pharma by acquiring remaining 25% stake

The JV successfully leveraged the strengths of both companies to better serve the fast-growing Indian market


Novartis and Medicines for Malaria Venture announce positive efficacy and safety data
Diagnostic Center | May 01, 2024

Novartis and Medicines for Malaria Venture announce positive efficacy and safety data

The CALINA study tested a new ratio and dose of Coartem to account for metabolic differences in babies under 5 kg


Lupin appoints Christoph Funke as Chief Technical Operations Officer
People | March 18, 2024

Lupin appoints Christoph Funke as Chief Technical Operations Officer

Christoph Funke's extensive career includes leadership roles at organizations such as Fresenius Kabi and Strides Pharma Science


ARTBIO and PharmaLogic inks supply agreement for Lead-212 based Therapeutic Candidate for  treatment of prostate cancer
Supply Chain | January 15, 2024

ARTBIO and PharmaLogic inks supply agreement for Lead-212 based Therapeutic Candidate for treatment of prostate cancer

PharmaLogic will assist ARTBIO with radiochemistry and supply of the finished radiopharmaceutical product for future Phase I and II clinical trials of AB001 from their facility in New York


Arco Lab acquires an additional 25% stake in Neviton at Rs. 9.22 Cr
News | January 08, 2024

Arco Lab acquires an additional 25% stake in Neviton at Rs. 9.22 Cr

Arco Lab now holds a 50% stake in Neviton


Stelis Biopharma updates on receipt of consideration from Syngene
News | December 25, 2023

Stelis Biopharma updates on receipt of consideration from Syngene

Syngene has completed a payment of Rs. 158.2 crores on December 22, 2023 in addition to the initial payment of Rs. 395 crores made on December 1, 2023


Glenmark Pharma reports Q2 FY24 loss at Rs. 62 Cr
News | November 13, 2023

Glenmark Pharma reports Q2 FY24 loss at Rs. 62 Cr

European operations' revenue grew 58.4% to Rs 599.7 crore


India should take global leadership with Holistic Healthcare Approach: Sonowal
Policy | October 23, 2023

India should take global leadership with Holistic Healthcare Approach: Sonowal

New Molecular biology lab launched, AIIA increased its work scope in form of MoUs